Thor Medical ASA (OSL:TRMED)

Thor Medical ASA Ratios and Metrics

Market cap in millions NOK. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 4, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Market Capitalization	1,568	1,859	738	301	-
Market Cap Growth	100.74%	151.99%	144.87%	-	-
Enterprise Value	1,559	1,643	709	-	-
Last Close Price	4.34	5.25	2.63	1.26	-
PS Ratio	1869.37	2215.62	-	-	-
PB Ratio	3.44	4.08	2.19	1.11	-
P/TBV Ratio	8.17	9.69	13.64	-	-
EV/Sales Ratio	-	1958.53	-	-	-
Debt / Equity Ratio	0.38	0.38	0.00	-	0.00
Net Debt / Equity Ratio	-0.02	-0.02	-0.36	-0.15	-1.54
Net Debt / EBITDA Ratio	0.18	0.18	2.92	6.12	-
Net Debt / FCF Ratio	0.08	0.08	5.09	0.65	0.24
Asset Turnover	0.00	0.00	-	-	-
Quick Ratio	4.46	4.46	5.65	10.05	2.30
Current Ratio	4.57	4.57	5.67	10.20	2.46
Return on Equity (ROE)	-14.63%	-14.63%	-13.86%	-3.31%	-
Return on Assets (ROA)	-7.75%	-7.75%	-7.37%	-2.03%	-
Return on Capital Employed (ROCE)	-10.50%	-10.50%	-11.20%	-2.20%	-
Earnings Yield	-3.70%	-3.12%	-5.72%	-8.82%	-
FCF Yield	-7.69%	-6.49%	-3.27%	-21.27%	-
Buyback Yield / Dilution	-40.80%	-40.80%	-34.90%	-51.82%	-

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jun 4, 2026

Data Sources Report a data error